Biblio Discovery — Demo Discovery Service

699 results

Showing 1–20 · 0.10 seconds · RSS

Journal

Hematology Reports

Scopus

ISSN 2038-8330 · MDPI AG · 699 articles in the index

  1. Journal Article Full text

    Factors Influencing the Use of G-CSF in Drug-Induced Agranulocytosis

    Emmanuel Andrès; Jean-Edouard Terrade; Xavier Jannot et al.

    Hematology Reports, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Drug-induced agranulocytosis is a rare but life-threatening adverse reaction associated with numerous non-chemotherapy drugs. Management relies on immediate drug withdrawal, infection control, and, in selected patients, administration of granulocyte-colony stimulating factor (G-CSF). This review…

  2. Journal Article Full text

    A Review of Patient-Reported Outcomes and Clinical Outcomes in Acute and Chronic Myeloid and Lymphoid Leukemias

    Bryan Chan; Eesha Balar; Seiichi Villalona et al.

    Hematology Reports, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Introduction: This review specifically focuses on interventional clinical trials in leukemias and myelodysplastic syndromes (MDS), summarizing how patient-reported outcome measures (PROMs) have been implemented to evaluate treatment effects rather than to directly influence clinical outcomes…

  3. Journal Article Full text

    Fluid Overload-Associated Large B-Cell Lymphoma Presenting as Isolated Pleural Effusion

    Kevin Leeper; Lauren Borecky; Mojtaba Akhtari et al.

    Hematology Reports, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Primary effusion-based lymphomas are uncommon and may pose significant diagnostic challenges. Fluid overload-associated large B-cell lymphoma is a recently recognized entity in the 5th edition of the World Health Organization Classification of Hematolymphoid Tumors and should be included in the…

  4. Journal Article Full text

    Paraneoplastic Neuro-Ophthalmologic Symptoms as Initial Manifestation of Hodgkin Lymphoma

    Sophie-Charlott Seidenfaden; Thomas Graversgaard Adams; Peter Kamper et al.

    Hematology Reports, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background and Clinical Significance: Patients with Hodgkin lymphoma (HL) often present with lymphadenopathy, biochemical inflammation, and constitutional symptoms, but may experience symptoms from extra-nodal organs. Symptoms are caused by either lymphoma or a paraneoplastic phenomenon but overt…

  5. Journal Article Full text

    Primary Indolent Acute Promyelocytic Leukemia

    Breanne Wolfenbarger; Daley Morera; Brandol Wolfenbarger et al.

    Hematology Reports, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background and Clinical Significance: Acute promyelocytic leukemia (APL) is a rapidly progressive subtype of acute myeloid leukemia defined by PML::RARA fusion and characterized by life-threatening coagulopathy. Because the disease typically follows an aggressive course, immediate treatment is…

  6. Journal Article Full text

    Fetal Safety of Intravenous Ferric Carboxymaltose in Pregnancy: A Cardiotocography Study from a Tertiary Care Hospital in Italy

    Francesca Polese; Chiara Pesce; Giulia De Fusco et al.

    Hematology Reports, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background: Iron-deficient anemia (IDA) in pregnant women is a significant health issue globally. Oral iron supplementation is the primary treatment for IDA during pregnancy. For women who do not respond to or cannot tolerate oral iron treatment, intravenous (IV) iron preparations may offer a…

  7. Journal Article Full text

    Primary Bone Lymphoma of the Jaw Masquerading as Infection and Delaying Treatment

    Emily Hamburger; Anne W. Beaven

    Hematology Reports, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background: Diffuse large B cell lymphoma is an aggressive, heterogeneous yet treatable disease. Primary bone lymphoma is a lymphoma involving a single or multiple osseous sites with or without regional nodal involvement. It is exceedingly rare, representing

  8. Journal Article Full text

    Bortezomib-Induced Sensorineural Hearing Loss May Be Reversible with Intratympanic Dexamethasone

    Natalia Peláez Casillas; Jose Maria Verdaguer Muñoz; Antonio Rodríguez Valiente et al.

    Hematology Reports, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background: Bortezomib, a proteasome inhibitor used in multiple myeloma (MM), is associated with several adverse effects, most notably peripheral neuropathy. Ototoxicity, however, remains a rare and underrecognized complication. Case presentation: We report the case of a 74-year-old man with MM who…

  9. Journal Article Full text

    Therapeutic Potential of Exportin 1 and Aurora Kinase A Inhibition in Multiple Myeloma Cells

    Seiichi Okabe; Yuko Tanaka; Shunsuke Otsuki et al.

    Hematology Reports, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background/Objectives: Aurora kinases (AURKs) are key regulators of mitosis, and their dysregulation contributes to plasma cell disorders, including multiple myeloma (MM) and plasma cell leukemia (PCL). Methods: The expression and prognostic relevance of AURK family members were examined, and the…

  10. Journal Article Full text

    Iron Therapy in Pediatric Iron Deficiency and Iron-Deficiency Anemia: Efficacy, Safety, and Formulation-Specific Trade-Offs—A Narrative Review

    Guido Leone; Marta Arrabito; Giovanna Russo et al.

    Hematology Reports, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background/Objectives: Iron deficiency (ID) is the most common nutritional disorder in childhood worldwide. It has profound consequences for growth, neurodevelopment, behaviour, and overall health. Despite the long-standing efficacy of oral ferrous salts, their poor gastrointestinal tolerability…

  11. Journal Article Full text

    The Global Gap in the Hemophilia Paradigm Shift: Disparities in Research, Care, and Musculoskeletal Health

    Felipe Querol-Giner; Magdalena Querol-Giner; Ana Chimeno-Hernández et al.

    Hematology Reports, Vol. 18 No. 3 · 2026 · English · DOAJ Scopus

    Background: Hemophilia care has undergone a major therapeutic transformation with the introduction of extended half-life products, non-replacement therapies, and gene therapy. However, the benefits of these advances are not equally distributed worldwide, and their impact on long-term…

  12. Journal Article Full text

    Digital Symptom Reporting for Treatment Readiness Before Daratumumab: A Blinded Prospective Study in Multiple Myeloma

    Tine Rosenberg; Jannie Kirkegaard; Michael Tveden Gundesen et al.

    Hematology Reports, Vol. 18 No. 3 · 2026 · English · DOAJ Scopus

    Objectives: For patients with multiple myeloma (MM), an increasing proportion of treatment is now delivered at home. While this shift offers convenience and supports continuity of care, it also demands new ways to ensure patient safety outside the hospital. Although patients receiving home-based…

  13. Journal Article Full text

    Quality of Life in CAR-T Cell Therapy

    Caterina Alati; Martina Pitea; Gaetana Porto et al.

    Hematology Reports, Vol. 18 No. 3 · 2026 · English · DOAJ Scopus

    Background: Chimeric antigen receptor T-cell (CAR-T) therapy has transformed the management of relapsed or refractory hematologic malignancies, achieving high response rates in B-cell acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and multiple myeloma. While the efficacy of CAR-T…

  14. Journal Article Full text

    Establishing Reference Intervals for White Blood Cell and Absolute Neutrophil Counts in Duffy Null Individuals

    Mohammad Barouqa; Muhammad Areeb Ashfaq; Katrina J. Jiang et al.

    Hematology Reports, Vol. 18 No. 3 · 2026 · English · DOAJ Scopus

    Background/Objectives: The Duffy (Fy) blood group system, encoded by the ACKR1 gene, plays a key role in transfusion medicine and host susceptibility to malarial infections such as Plasmodium vivax. The Duffy-null phenotype [Fy(a−b−)] is associated with lower baseline white blood cell (WBC) and…

  15. Journal Article Full text

    Perioperative Anemia, Transfusion Practices, and Patient Blood Management: Lessons from the COVID-19 Pandemic

    Alin Ionescu; Alexandra Mihăilescu; Raluca Dumache et al.

    Hematology Reports, Vol. 18 No. 3 · 2026 · English · DOAJ Scopus

    The COVID-19 pandemic exposed vulnerabilities in global blood supply systems and accelerated the adoption of patient blood management (PBM) strategies aimed at optimizing transfusion practices in surgical care. Perioperative anemia is a key contributor to adverse outcomes and is frequently treated…

  16. Journal Article Full text

    Bortezomib in Patients Who Fail BTKi in Waldenström Macroglobulinaemia

    Jahanzaib Khwaja; Nicole Japzon; Simona Gatto et al.

    Hematology Reports, Vol. 18 No. 3 · 2026 · English · DOAJ Scopus

    Background: Treatment options after Bruton’s tyrosine kinase inhibitors (BTKi) failure in Waldenstrom macroglobulinaemia are limited. Methods: We retrospectively analysed the use of bortezomib after BTKi failure in 17 patients who were heavily pre-treated and chemotherapy-exposed at our centre…

  17. Journal Article Full text

    Eltrombopag for Chemotherapy-Induced Thrombocytopenia: A Multicenter Retrospective Real-World Study

    Mehmet Baysal; Fatos Dilan Köseoğlu; Sevil Sadri et al.

    Hematology Reports, Vol. 18 No. 3 · 2026 · English · DOAJ Scopus

    Introduction: Chemotherapy-induced thrombocytopenia (CIT) is a common dose-limiting toxicity that disrupts on-time, full-dose chemotherapy, yet no pharmacologic therapy is formally approved. Growing evidence from randomized and late-phase studies with thrombopoietin receptor agonists (TPO-RAs) has…

  18. Journal Article Full text

    Novel Approaches to the Management of Myelodysplastic Syndromes: The Roles of Artificial Intelligence and Oxidative Stress Biomarkers

    Ioannis Tsamesidis; Georgios Drillis; Sotirios Varlamis et al.

    Hematology Reports, Vol. 18 No. 3 · 2026 · English · DOAJ Scopus

    Objectives: Myelodysplastic syndromes (MDSs) are a heterogeneous group of clonal hematopoietic disorders characterized by ineffective hematopoiesis, genomic instability, and a high risk of progression to acute myeloid leukemia. Oxidative stress (OS) has emerged as a central factor in MDS…

  19. Journal Article Full text

    Sociodemographic, Clinical, and Therapeutic Characterization of Multiple Myeloma Patients (CharisMMa Study) with Symptomatic Relapse and/or Refractory Disease: An Observational, Multicenter Study in Portugal

    Rui Bergantim; José Guilherme Freitas; Cristina Gonçalves et al.

    Hematology Reports, Vol. 18 No. 3 · 2026 · English · DOAJ Scopus

    Objectives: Real-world information on relapsed and/or refractory multiple myeloma (rrMM) clinical management in Portugal is scarce. The CharisMMa Portugal study aimed to characterize rrMM patients through socio-demographic and clinical parameters and describe treatment patterns. Methods: This was…

  20. Journal Article Full text

    Leukemic Non-Nodal Mantle Cell Lymphoma Presenting with Traumatic Splenic Rupture

    Moinul Haque; Razie Amraei; Krasimira A. Rozenova

    Hematology Reports, Vol. 18 No. 3 · 2026 · English · DOAJ Scopus

    Background: Leukemic non-nodal variant mantle cell lymphoma (nnMCL) is an uncommon subtype of mantle cell lymphoma that lacks lymphadenopathy and generally follows an indolent clinical course. Adverse genetic alterations such as TP53 inactivation and del(13q) may have prognostic significance…